We are looking for children 2 to 17 years old to join a CD trial to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or moderately to severely active ulcerative colitis (including associated symptoms such as abdominal pain and cramps, blood in the stool, constant need to poop, weight loss and/or canker sores), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years old may be eligible to take part.
Your child may be eligible to take part in the IBD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child is eligible.
